These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 18417901)
1. Sarcomatoid squamous cell carcinoma of uterine cervix: pathology, imaging, and treatment. Kumar M; Bahl A; Sharma DN; Agarwal S; Halanaik D; Kumar R; Rath GK J Cancer Res Ther; 2008; 4(1):39-41. PubMed ID: 18417901 [TBL] [Abstract][Full Text] [Related]
2. Sarcomatoid squamous cell carcinoma of the uterine cervix: case report. Rodrigues L; Santana I; Cunha T; Félix A; Freire J; Cabral I Eur J Gynaecol Oncol; 2000; 21(3):287-9. PubMed ID: 10949396 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix]. Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134 [TBL] [Abstract][Full Text] [Related]
4. Sarcomatoid squamous cell carcinoma of the uterine cervix with osteoclast-like giant cells: report of two cases. Pang LC Int J Gynecol Pathol; 1998 Apr; 17(2):174-7. PubMed ID: 9553816 [TBL] [Abstract][Full Text] [Related]
5. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431 [TBL] [Abstract][Full Text] [Related]
6. Splenic metastases from cervical carcinoma: a case report. Gupta T; Nair N; Fuke P; Bedre G; Basu S; Shrivastava SK Int J Gynecol Cancer; 2006; 16(2):911-4. PubMed ID: 16681784 [TBL] [Abstract][Full Text] [Related]
7. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix. Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer. Yilmaz B; Dağ S; Ergul N; Çermik TF Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896 [TBL] [Abstract][Full Text] [Related]
9. Roles of posttherapy Liu FY; Su TP; Wang CC; Chao A; Chou HH; Chang YC; Yen TC; Lai CH Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1197-1204. PubMed ID: 29470614 [TBL] [Abstract][Full Text] [Related]
10. [Glassy cell carcinoma of the cervix]. Dieterle S; Mesrogli M; Günter HH; Kühnle H Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):484-5. PubMed ID: 1909675 [TBL] [Abstract][Full Text] [Related]
11. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET. Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130 [TBL] [Abstract][Full Text] [Related]
12. Rapid developing basaloid squamous cell carcinoma of the uterine cervix in a young adult Taiwanese. Tsai HJ; Liou B; Li MC Malays J Pathol; 2013 Dec; 35(2):177-80. PubMed ID: 24362481 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in squamous cell carcinoma of the cervix uteri: present role and perspectives. Pignata S; De Vivo R; Ricchi P; Perrone F; Botti G; Monfardini S Cancer Treat Rev; 1998 Feb; 24(1):27-34. PubMed ID: 9606366 [No Abstract] [Full Text] [Related]
14. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy. Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer. Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928 [TBL] [Abstract][Full Text] [Related]
16. Clinical impact of 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-positron emission tomography (PET) on treatment choice in recurrent cancer of the cervix uteri. Bjurberg M; Brun E Int J Gynecol Cancer; 2013 Nov; 23(9):1642-6. PubMed ID: 24177254 [TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary approach in the pelvic relapse of a previously irradiated cervical tumor. Vázquez-Vicente D; Castellanos T; Cabello A; Chacon E; Minguez JA; Chiva L Int J Gynecol Cancer; 2020 May; 30(5):714. PubMed ID: 32122948 [No Abstract] [Full Text] [Related]
18. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix. Hashmi H; Maqbool A; Ahmed S; Ahmed A; Sheikh K; Ahmed A J Coll Physicians Surg Pak; 2016 Apr; 26(4):302-5. PubMed ID: 27097702 [TBL] [Abstract][Full Text] [Related]
19. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent. Narayan K; Fisher RJ; Bernshaw D; Shakher R; Hicks RJ Int J Gynecol Cancer; 2009 Jul; 19(5):912-8. PubMed ID: 19574784 [TBL] [Abstract][Full Text] [Related]
20. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy. Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]